Elefante Mark B as of March 31, 2017
Portfolio Holdings for Elefante Mark B
Elefante Mark B holds 27 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fiserv (FI) | 6.0 | $658k | 5.7k | 115.35 | |
Apple (AAPL) | 6.0 | $656k | 4.6k | 143.81 | |
Procter & Gamble Company (PG) | 5.0 | $552k | 6.1k | 89.94 | |
MasterCard Incorporated (MA) | 4.9 | $544k | 4.8k | 112.45 | |
Johnson & Johnson (JNJ) | 4.7 | $515k | 4.1k | 124.72 | |
CVS Caremark Corporation (CVS) | 4.5 | $499k | 6.4k | 78.55 | |
Alphabet Inc Class A cs (GOOGL) | 4.5 | $495k | 583.00 | 848.33 | |
Chubb (CB) | 4.3 | $479k | 3.5k | 136.36 | |
3M Company (MMM) | 4.3 | $478k | 2.5k | 191.03 | |
Automatic Data Processing (ADP) | 4.3 | $479k | 4.7k | 102.37 | |
United Technologies Corporation | 4.1 | $455k | 4.1k | 112.33 | |
Novartis (NVS) | 3.8 | $418k | 5.6k | 74.36 | |
Nestle SA Reg Shs. Ser. B Spons (NSRGY) | 3.7 | $406k | 5.3k | 76.97 | |
Rockwell Automation (ROK) | 3.7 | $404k | 2.6k | 155.37 | |
Exxon Mobil Corporation (XOM) | 3.5 | $391k | 4.8k | 82.06 | |
Abbott Laboratories (ABT) | 3.5 | $390k | 8.8k | 44.33 | |
Danaher Corporation (DHR) | 3.5 | $381k | 4.5k | 85.57 | |
Aptar (ATR) | 3.3 | $363k | 4.7k | 77.02 | |
Unilever (UL) | 3.2 | $356k | 7.2k | 49.34 | |
Canadian Natl Ry (CNI) | 3.0 | $329k | 4.5k | 73.79 | |
Roche Holding (RHHBY) | 2.9 | $324k | 10k | 32.01 | |
Schlumberger (SLB) | 2.7 | $297k | 3.8k | 78.24 | |
Analog Devices (ADI) | 2.4 | $268k | 3.3k | 82.12 | |
Pepsi (PEP) | 2.1 | $234k | 2.1k | 112.04 | |
Oracle Corporation (ORCL) | 2.1 | $231k | 5.2k | 44.67 | |
Xylem (XYL) | 2.0 | $222k | 4.4k | 50.35 | |
Illumina (ILMN) | 1.9 | $206k | 1.2k | 170.21 |